Outsourcing

 

Why Westminster NHS systems fail

Profound pessimism about NHS plans for integrated health and with NHS systems in the UK and Canada was on display from academics at the European Health Policymakers Group which celebrated its 21st year in an afternoon looking at what the group had learnt studying Beveridge (NHS) and Bismarckian (statutory insurer) models.

Spain “too reliant” on for profits to pull the plug

The Spanish government has put forward a draft bill to strengthen its NHS system, and wean it off the private sector. A well-placed source at HBI 2022 tells us that for-profits are so entrenched and vital to Spain's NHS system that attempts to remove them would be too catastrophic, meaning a wholesale removal is highly unlikely. The bill still needs to pass the legislature before it becomes law. 

Warsaw hub model set to spread across CEE

A new Warsaw Health Innovation Hub in Poland has seen 30 big pharma and medtech contribute brains and money to tackle healthcare projects, extending the cooperation which developed during Covid between the government and the private sector. Healthcare providers are set to join. The model is likely to be adopted by other CEE countries.

“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.

Finnish SOTE reform ‘could create more outsourcing opportunities’

In July 2021, Finland’s leftist parliament passed the long-awaited SOTE reform to its healthcare system, which amalgamated 309 municipal health authorities into 21 much larger ‘welfare regions’. HBI speaks to analysts and operators to find out what impact the reform is having on the for-profit sector.

Stanley Capital acquires DSS

Stanley Capital, the London-based private equity fund, is to buy Drug Safety and Pharmacovigilance Services Solutions ("DSS") from Clario, a global clinical trials player. "DDS" specializes in pharmacovigilance - the assessment and monitoring of interactions between drugs and their effects on the human body. HBI talks to Simon Cottle, the founding partner at Stanley Capital.

Public health services in Helsinki outsourced to Mehiläinen

Finnish outpatient and occupational healthcare specialist Mehiläinen has been chosen as a provider of public primary health services in Helsinki. This is the first time that public care outsourcing has happened in the capital, Markku Näreneva, Mehiläinen's Director of Public Health Services tells HBI.

Interview: Mark Chapman, International CEO, Life Healthcare

What are South African hospital group Life Healthcare's plans for its international division, mainly comprised of pan-European imaging operator Alliance Medical? In a long and wide-ranging discussion, Chapman talks about expansion in South Africa and one to two new countries, 'winners and losers' in the imaging AI market, tariff pressure across Europe and what the first new potential drug therapy for Alzheimer's in 18 years means for its PET-CT business.

Find Us